1. Home
  2. FSI vs KPTI Comparison

FSI vs KPTI Comparison

Compare FSI & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$6.86

Market Cap

86.6M

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$5.80

Market Cap

94.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
KPTI
Founded
1991
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.6M
94.6M
IPO Year
1999
2013

Fundamental Metrics

Financial Performance
Metric
FSI
KPTI
Price
$6.86
$5.80
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$22.17
AVG Volume (30 Days)
56.4K
114.4K
Earning Date
11-14-2025
11-03-2025
Dividend Yield
1.45%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$38,563,427.00
$142,530,000.00
Revenue This Year
$8.45
$3.82
Revenue Next Year
$51.24
$3.18
P/E Ratio
$49.13
N/A
Revenue Growth
0.18
N/A
52 Week Low
$3.46
$3.51
52 Week High
$11.48
$12.45

Technical Indicators

Market Signals
Indicator
FSI
KPTI
Relative Strength Index (RSI) 37.77 50.33
Support Level $6.35 $5.30
Resistance Level $7.13 $6.05
Average True Range (ATR) 0.43 0.44
MACD 0.02 0.02
Stochastic Oscillator 32.90 37.50

Price Performance

Historical Comparison
FSI
KPTI

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: